Health Condition 1: G620- Drug-induced polyneuropathy
Conditions
Interventions
None listed
Sponsors
Department of Kayachikitsa Faculty of Ayurveda IMS BHU
Eligibility
Inclusion criteria
Inclusion criteria: 1. Aged between 15-60 years including either sex. 2. Diagnosed cases of chemotherapy induced peripheral neuropathy. 3. Patient willing to participate in the above trial and giving informed consent. 4. Patients screened with Nerve Conduction study (NCS) and Surface Electromyography(EMG), (when necessary).
Exclusion criteria
Exclusion criteria: 1. Aged higher than 60 years including either sex. 2. Cases with the co-occurrence of neuropathy before the start of chemotherapy (e.g., diabetic neuropathy) 3. Pregnant and lactating women. 4. Patients with known case of Diabetes Mellitus 5. Patients with low level of vitamin B-12( 6. Patients with impaired renal function with reduced clearance 7. Patients with implanted cardiac pacemakers and defibrillators. 8. Patients exposed exposure to other neurotoxic chemotherapeutic agents already 9. Patients with independent, direct cancer-associated neuropathy. 10. Patients who took any other medication or discontinue the trial period without information of the investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Subjective symptoms assessment by European Organization for Research and Treatment of Cancer, EORTC QLQ ââ?¬â?? CIPN20 (includes symptoms of vata-pitta janya vikara)Timepoint: 3 months Treatment course will be given for 3 months & 3 follow ups -before treatment, after 45 days, and after 3 months will be recorded | — |
Secondary
| Measure | Time frame |
|---|---|
| 1)Objective assessment by, a. Nerve Conduction Study (NCS) b. Electromyography (EMG) c. Hematological study Timepoint: 3 Months Treatment course will be given for 3 months & 3 follow ups -before treatment, after 45 days, and after 3 months will be recorded | — |
Countries
India
Contacts
Public ContactProf OP Singh
Banaras Hindu University
Outcome results
None listed